ClickCease

Earnings call 3Q26

Phase 2 data recap with Najat Khan, Ph.D.

Najat Khan, Ph.D., President and CEO of Recursion, presents the REC-4881 update from the 3Q26 earnings webinar: unmet need in FAP, how Recursion's platform identified MEK1/2 inhibition, updated TUPELO results for total, upper GI and lower GI polyp burden at Weeks 13 and 25, Spigelman staging, and safety to prepare for a registrational trial in 2H 2027.

KOL panel

Evelien Dekker, M.D., Ph.D. (Amsterdam UMC) and Bryson Katona, M.D., Ph.D. (University of Pennsylvania) join Vicki Goodman, M.D., Chief Medical Officer of Recursion, to discuss the updated TUPELO data, the current management of FAP, and the role of upper and lower GI disease in post-colectomy patients.

Patient panel

Laura and Jesse Laster, and Lindsay Huff join Vicki Goodman, M.D., Chief Medical Officer of Recursion, to discuss their experiences with FAP, including surgery, ongoing surveillance, and family planning.

© 2026 Recursion. All rights reserved.